Fidelity Investments’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12B Sell
24,845,364
-684,521
-3% -$182M 0.52% 29
2026
Q1
$2.8B Buy
25,529,885
+194,944
+0.8% +$27.8M 0.15% 113
2025
Q4
$4.21B Buy
25,334,941
+1,255,455
+5% +$210M 0.21% 62
2025
Q3
$4.71B Sell
24,079,486
-724,560
-3% -$119M 0.25% 49
2025
Q2
$2.24B Buy
24,804,046
+681,304
+3% +$53.8M 0.13% 125
2025
Q1
$1.44B Buy
24,122,742
+711,968
+3% +$65.9M 0.09% 179
2024
Q4
$3.1B Sell
23,410,774
-93,264
-0.4% -$8.75M 0.19% 81
2024
Q3
$1.23B Buy
23,504,038
+153,491
+0.7% +$7.2M 0.07% 222
2024
Q2
$1.41B Buy
23,350,547
+6,946,576
+42% +$482M 0.09% 172
2024
Q1
$1.22B Buy
+16,403,971
New +$1.22B 0.08% 211

Other funds holding ALAB

Fidelity Investments's ALAB Position: Q2 2026 in Review

Fidelity Investments reduced its Astera Labs (ALAB) stake by 2.7% in Q2 2026, selling an estimated $182M and leaving 24,845,364 shares worth $12B. The position accounts for 0.52% of the portfolio, ranked #29.

Fidelity Investments first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Fidelity Investments held 24,845,364 shares of Astera Labs worth $12B as of Q2 2026.
  • Fidelity Investments sold 684,521 Astera Labs shares in Q2 2026, an estimated $182M.
  • Astera Labs made up 0.52% of Fidelity Investments's portfolio in Q2 2026, its #29 holding.
  • Fidelity Investments first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.